Navigation Links
First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
Date:5/23/2013

BEDFORD, Mass., May 23, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that the first large-scale observational study in a U.S. clinical practice comparing breast cancer screening with Hologic's 3D mammography technology (breast tomosynthesis) with conventional 2D mammography alone showed a significant reduction in recall rates and a sizeable increase in cancer detection, particularly invasive cancer, across all breast tissue densities. Published in the June issue of the American Journal of Roentgenology (AJR), the study evaluated recall, biopsy, cancer detection and invasive cancer detection rates in a community-based breast imaging practice. The study was issued online in advance of print on May 23, 2013.

The study, "Implementation of Breast Tomosynthesis in a Routine Screening Practice: An Observational Study"[i] was led by Stephen L. Rose , M.D., President and Founder of Rose Imaging, Medical Director of TOPS Comprehensive Breast Center, and Breast Radiologist affiliated with Memorial Hermann Health System in Houston, Texas. The analysis compared the outcomes of 2D mammography screening exams that were interpreted prior to the introduction of Hologic's 3D mammography, with screening exams after the introduction of 3D mammography into the practice.

The Rose study found that the use of Hologic's 3D mammography resulted in:

  • A  significant 38% drop in recall rates – from 8.7% to 5.5% (p < 0.001)
  • An 11%  drop in biopsy rates - from 15.2 to 13.5 per 1,000 screenings (p = 0.59)
  • A 35% increase in cancer
    '/>"/>

  • SOURCE Hologic, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System
    2. Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis
    3. Medifirst Solutions, Inc. Announces Update To Shareholders
    4. Concord Medical Reports First Quarter 2013 Financial Results
    5. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
    6. ConvaTec Announces 2013 First Quarter Earnings Call
    7. Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results
    8. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
    9. ULURU Inc. Reports First Quarter 2013 Financial Results
    10. Access Pharmaceuticals Reports First Quarter Results
    11. SOAPware President Randall Oates, M.D. Among First NCQA Certified Patient-Centered Medical Home Content Experts
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... July 2, 2015 Releases of ... Aedes aegypti , , reduced the dengue ... Brazil by 95%, well below the modelled ... http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal PLOS Neglected Tropical ... Oxitec,s genetically engineered mosquitoes. The results showed that in ...
    (Date:7/2/2015)... According to a new market research report " ... Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, Epilepsy, Ischemia, ... the global Neuromodulation Market is estimated at $3.65 Billion in ... at a CAGR of 11.2% during the forecast period. ... market data T ables and 32 ...
    (Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) has announced the addition ... Application - Forecast to 2020" report to their offering. ... Billion in 2020 from an estimated $7.1 Billion in 2015, growing ... by North America , followed by ... the World (RoW). The cancer diagnostics market in Asia ...
    Breaking Medicine Technology:Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2
    ... Feb. 16, 2012 Mylan Inc. (Nasdaq: ... ) today announced that Meridian Medical Technologies, a Pfizer ... and Sanofi-Aventis that will resolve pending patent litigation related ... epinephrine auto-injector known as e-cue™, which will be manufactured ...
    ... Acknowledging the importance of dedicated information management systems ... demonstrate the most recent version of its MOSAIQ® ... and Management Systems Society,s 2012 conference (HIMSS12), Feb. ... is a comprehensive OIS that centralizes traditional radiation ...
    Cached Medicine Technology:Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement 2Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement 3Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement 4Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement 5Elekta Highlights Latest Version of MOSAIQ Oncology Information System at HIMSS12 Meeting 2
    (Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression ... compression socks designed for men. , For style that’s quick on its feet, ... routine. This is great news for men everywhere because a simple change in socks ...
    (Date:7/2/2015)... ... July 02, 2015 , ... ... provides comprehensive information on the pipeline products with comparative analysis of the ... therapy (NPWT) with 22 market data tables and 4 figures, spread across ...
    (Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough ... wrist pain treatment. Dr. Lev Kalika, founder of New York Dynamic Neuromuscular ... authority on the conservative treatment of back, hip, knee and shoulder pain as ...
    (Date:7/2/2015)... , ... July 02, 2015 , ... Hand sanitizers have ... current summer flu season, according to fresh water advocate and radio host Sharon Kleyne, ... hands. Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied correctly and ...
    (Date:7/2/2015)... ... July 02, 2015 , ... The report summarizes key statistics ... report is a valuable source of guidance and direction for companies and individuals ... for the Gelatin Capsule industry including capacity, production, production value, cost and profit, ...
    Breaking Medicine News(10 mins):Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4
    ... Farms, a national,ground beef producer, is issuing a voluntary ... N.Y., facility and sold through Price,Chopper, Shaw,s, BJ,s, and ... affected product may contain small pieces of hard plastic. ... 05/15/08, or a,"Julian date 124" on the package,s label. ...
    ... 12 MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) today ... 2008., The net loss for the first quarter ... million during the same period in 2007. As of,March ... investments of $81.1 million., First Quarter Financial Results, ...
    ... prevented heart failure in those with Duchenne muscular dystrophy ... Duchenne muscular dystrophy often suffer from heart failure, but ... condition, a new Canadian study finds. , In experiments ... performance by preventing the breakdown of a compound called ...
    ... WASHINGTON, May 12 Most baby boomers say,they ... to a,new survey conducted by Harris Interactive on ... would have difficulty paying bills and,many would have ... disability,occurred., (Logo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGO ), ...
    ... Effective May 19, the Texas,Hospital Association will have a ... 1108 Lavaca, located within steps of the Texas Capitol., ... Association,and a group of investors, THA was able to ... our members," said Dan Stultz, M.D., FACP, FACHE,president/CEO of ...
    ... MONTREAL, May 12 /PRNewswire-FirstCall/ - CryoCath(R) Technologies,Inc., the ... announced financial results for the second quarter,ended March 31, ... Highlights:, - Accelerated revenue growth in ... increase over comparable electrophysiology (EP) ...
    Cached Medicine News:Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 2Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 3Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 4Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 5Health News:Viagra May Protect Hearts of Some Muscular Dystrophy Patients 2Health News:Most Baby Boomers are Financially Unprepared for a Potential Disability 2Health News:Hospital Association Moves Headquarters to Downtown Austin 2Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 2Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 3Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 4Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 5Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 6Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 7Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 8Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 9Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 10Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 11Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 12
    ... Airial Handheld Ultrasonic Nebulizer has ... This compact, portable, and lightweight ... fast & quite treatments operating ... or DC auto adapter. , ...
    With ten colors available, Spectrums line of Color-Coded Fiberoptic Light Cables makes it easy to track by department....
    Lumitex® LightMat® Surgical Illuminator improves visualization in deep cavity surgery. Flexible and malleable, it attaches easily to most retractors, bringing bright, cool area lighting where...
    ... the exceptional performance you need at a price ... and durability youd expect from headlights priced much ... features our thinnest cable and adjusts from 90 ... when you reach for a headlight you can ...
    Medicine Products: